Confirmed graft flow following use of recombinant factor VIIa in coronary artery bypass grafting: a case report and literature review.
We present our experience of a unique opportunity to survey coronary artery bypass graft (CABG) patency following the administration of recombinant factor VIIa in the early postoperative period. A review of the published literature on use of this medication in cardiothoracic surgery, specifically CABG, is included.